SCHEMBL6929942

SCHEMBL6929942

O=C1NC(=O)C(=Cc2cccc(NC(=O)c3ccccc3NS(=O)(=O)c3ccccc3)c2)S1

nearest known ligand 0.51

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MEN1 O00255 5/20 0.51
KMT2A Q03164 5/20 0.51
SLC10A2 Q12908 1/20 0.48
SLC10A1 Q14973 1/20 0.48
SLC10A6 Q3KNW5 1/20 0.48
SMN1; SMN2 Q16637 3/20 0.48
ALDH1A1 P00352 2/20 0.48
HPGD P15428 2/20 0.48
PIM1 P11309 5/20 0.47
PIM2 Q9P1W9 5/20 0.47
PIM3 Q86V86 1/20 0.47
USP2 O75604 1/20 0.47
TDP1 Q9NUW8 1/20 0.47
LMNA P02545 2/20 0.47
KDM4E B2RXH2 1/20 0.47
CYP3A4 P08684 1/20 0.47
CYP2D6 P10635 1/20 0.47
CYP2C9 P11712 1/20 0.47
CRHBP P24387 1/20 0.47
CYP2C19 P33261 1/20 0.47

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6929933 0.87 KMT2A (0.51) MEN1KMT2ASMN1; SMN2ALDH1A1PIM1
SCHEMBL6929936 0.87 KMT2A (0.51) MEN1KMT2ASMN1; SMN2ALDH1A1PIM1
SCHEMBL6927181 0.79 MEN1 (0.52) MEN1KMT2ASMN1; SMN2PIM1PIM2
SCHEMBL6927180 0.79 MEN1 (0.52) MEN1KMT2ASMN1; SMN2PIM1PIM2
SCHEMBL6927087 0.79 NAMPT (0.51) MEN1KMT2ASMN1; SMN2ALDH1A1HPGD
SCHEMBL6927082 0.79 NAMPT (0.51) MEN1KMT2ASMN1; SMN2ALDH1A1HPGD
SCHEMBL6926883 0.79 AKR1B1 (0.53) PIM1PIM2PIM3AKR1B1HDAC4
SCHEMBL6928703 0.77 PIM1 (0.55) HPGDPIM1PIM2PIM3AKR1B1
SCHEMBL6928700 0.77 PIM1 (0.55) HPGDPIM1PIM2PIM3AKR1B1
SCHEMBL6928941 0.77 AKR1B1 (0.48) PIM1PIM2PIM3AKR1B1HDAC4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6518268-B1 Telomerase inhibitors and methods of their use GERON CORPORATION 2003-02-11 US disclosed
WO-2001002377-A9 TELOMERASE INHIBITORS AND METHODS OF THEIR USE GERON CORP (US) 2001-10-11 WO disclosed
EP-1109796-A1 TELOMERASE INHIBITORS AND METHODS OF THEIR USE Geron Corporation (US) 2001-06-27 EP disclosed
WO-2001002377-A1 TELOMERASE INHIBITORS AND METHODS OF THEIR USE GERON CORPORATION (US) 2001-01-11 WO disclosed